In the present study, we showed that ITGB6 interacts with the inactive EGFR in NSCLC, whereas in SCLC, ITGB2 reduces the levels of ITGB6, and interacts with and activates EGFR. This evidence concerns the gene ITGB6 and small cell lung carcinoma.